Log in

TSE:CLSCelestica Stock Price, Forecast & News

C$9.27
-0.11 (-1.17 %)
(As of 06/2/2020 07:38 AM ET)
Add
Compare
Today's Range
C$9.08
Now: C$9.27
C$9.41
50-Day Range
C$5.82
MA: C$7.71
C$9.38
52-Week Range
C$3.83
Now: C$9.27
C$12.27
Volume156,700 shs
Average Volume392,326 shs
Market CapitalizationC$1.20 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Celestica Inc. provides design, manufacturing, hardware platform, and supply chain solutions in Canada and internationally. It operates through two segments, Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of services, including design and development, engineering, supply chain management, new product introduction, component sourcing, electronics manufacturing, assembly and test, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services. It serves the aerospace and defense, industrial, smart energy, healthtech, capital equipment, enterprise communications, telecommunications, servers, and storage businesses. The company was incorporated in 1996 and is headquartered in Toronto, Canada.
Read More
Celestica logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.73 out of 5 stars


Industry, Sector and Symbol

Industry Contract Manufacturers
Sub-IndustryN/A
SectorComputer and Technology
CUSIPN/A
CIKN/A
Phone+1-416-4485800

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$5.77 billion
Cash FlowC$3.80 per share
Book ValueC$10.37 per share

Profitability

Miscellaneous

Employees23,600
Market CapC$1.20 billion
Next Earnings Date7/22/2020 (Estimated)
OptionableOptionable

Receive CLS News and Ratings via Email

Sign-up to receive the latest news and ratings for CLS and its competitors with MarketBeat's FREE daily newsletter.

Celestica (TSE:CLS) Frequently Asked Questions

How has Celestica's stock been impacted by COVID-19 (Coronavirus)?

Celestica's stock was trading at C$6.99 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CLS shares have increased by 32.6% and is now trading at C$9.27. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Celestica?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Celestica in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Celestica.

When is Celestica's next earnings date?

Celestica is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for Celestica.

How were Celestica's earnings last quarter?

Celestica Inc (TSE:CLS) released its quarterly earnings data on Wednesday, April, 29th. The company reported $0.22 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.10 by $0.12. The business earned $1.77 billion during the quarter, compared to the consensus estimate of $1.73 billion. View Celestica's earnings history.

What price target have analysts set for CLS?

2 equities research analysts have issued 1-year price objectives for Celestica's stock. Their forecasts range from C$6.50 to C$8.50. On average, they anticipate Celestica's stock price to reach C$7.50 in the next twelve months. This suggests that the stock has a possible downside of 19.1%. View analysts' price targets for Celestica.

Has Celestica been receiving favorable news coverage?

Headlines about CLS stock have trended very positive recently, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Celestica earned a daily sentiment score of 3.5 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutCelestica.

Who are some of Celestica's key competitors?

What other stocks do shareholders of Celestica own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Celestica investors own include Quantum (QTM), Aurora Cannabis (ACB), Canarc Resource (CCM), Shopify (SHOP), First Quantum Minerals (FM), Nutrien (NTR), Barrick Gold (ABX), Bank of America (BAC), Biogen (BIIB) and B2Gold (BTO).

Who are Celestica's key executives?

Celestica's management team includes the following people:
  • Mr. Robert Andrew Mionis, Pres, CEO & Director (Age 56)
  • Mr. Mandeep Chawla, Chief Financial Officer (Age 42)
  • Mr. Todd Cooper, Chief Operations Officer (Age 49)
  • Mr. Michael P. McCaughey, Advisor (Age 57)
  • Mr. John Joseph Lawless, Pres of Advanced Technology Solutions (Age 58)

What is Celestica's stock symbol?

Celestica trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CLS."

How do I buy shares of Celestica?

Shares of CLS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Celestica's stock price today?

One share of CLS stock can currently be purchased for approximately C$9.27.

How big of a company is Celestica?

Celestica has a market capitalization of C$1.20 billion and generates C$5.77 billion in revenue each year. Celestica employs 23,600 workers across the globe.

What is Celestica's official website?

The official website for Celestica is www.celestica.com.

How can I contact Celestica?

Celestica's mailing address is 844 Don Mills Rd, NORTH YORK, ON M3C 1V7, Canada. The company can be reached via phone at +1-416-4485800.

This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.